Free Trial

Cresco Labs Inc. (OTCMKTS:CRLBF) Receives Consensus Rating of "Buy" from Analysts

Cresco Labs logo with Medical background

Cresco Labs Inc. (OTCMKTS:CRLBF - Get Free Report) has been given a consensus recommendation of "Buy" by the four ratings firms that are presently covering the firm, MarketBeat Ratings reports. Two analysts have rated the stock with a hold rating and two have given a strong buy rating to the company.

Separately, Cormark raised Cresco Labs from a "hold" rating to a "moderate buy" rating in a research report on Monday, March 17th.

Read Our Latest Stock Report on Cresco Labs

Cresco Labs Price Performance

OTCMKTS:CRLBF traded up $0.03 during trading hours on Monday, reaching $0.72. The company had a trading volume of 280,110 shares, compared to its average volume of 628,490. The stock has a 50-day moving average of $0.71 and a two-hundred day moving average of $0.91. Cresco Labs has a one year low of $0.52 and a one year high of $2.35. The firm has a market capitalization of $353.58 million, a PE ratio of -3.60 and a beta of 1.73. The company has a quick ratio of 1.39, a current ratio of 1.97 and a debt-to-equity ratio of 1.80.

Cresco Labs (OTCMKTS:CRLBF - Get Free Report) last issued its quarterly earnings results on Friday, March 14th. The company reported ($0.01) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.01). Cresco Labs had a negative return on equity of 16.52% and a negative net margin of 9.15%. The business had revenue of $176.00 million for the quarter, compared to analyst estimates of $172.10 million. Analysts forecast that Cresco Labs will post -0.2 earnings per share for the current year.

About Cresco Labs

(Get Free Report

Cresco Labs Inc, together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand.

Recommended Stories

Should You Invest $1,000 in Cresco Labs Right Now?

Before you consider Cresco Labs, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cresco Labs wasn't on the list.

While Cresco Labs currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Dirt-Cheap Stocks in a Market That’s Getting Expensive
Top 3 Defense Stocks to Profit From $175 Billion Golden Dome
Top 5 Stocks for June: AI Picks That Aren’t NVIDIA

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines